These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 1349827)

  • 1. Neuroleptic malignant syndrome: a preventive program.
    Fernando ML; Manchanda R; Kirk C
    J Psychiatry Neurosci; 1992 Mar; 17(1):31-3. PubMed ID: 1349827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catatonic variants, hyperthermic extrapyramidal reactions, and subtypes of neuroleptic malignant syndrome.
    Lee JW
    Ann Clin Psychiatry; 2007; 19(1):9-16. PubMed ID: 17453656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with neuroleptic malignant syndrome histories: what happens when they are rehospitalized?
    Gelenberg AJ; Bellinghausen B; Wojcik JD; Falk WE; Farhadi AM
    J Clin Psychiatry; 1989 May; 50(5):178-80. PubMed ID: 2565897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rhabdomyolysis in neuroleptic therapy: an abortive malignant neuroleptic syndrome?].
    Peschel O; Kurtz G; Müller-Felber W; Modell S
    Nervenarzt; 1994 Oct; 65(10):718-21. PubMed ID: 7808573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinguishing neuroleptic malignant syndrome (NMS) from NMS-like acute medical illnesses: a study of 34 cases.
    Sewell DD; Jeste DV
    J Neuropsychiatry Clin Neurosci; 1992; 4(3):265-9. PubMed ID: 1354002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine.
    Paparrigopoulos T; Tzavellas E; Ferentinos P; Mourikis I; Liappas J
    World J Biol Psychiatry; 2009; 10(1):70-3. PubMed ID: 19673089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies of risk factors and preventive care for neuroleptic malignant syndrome].
    Tanii H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Nov; 26(5-6):177-81. PubMed ID: 17240842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
    Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
    Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuroleptic malignant syndrome].
    Dahm JB; Trenckmann U
    Med Klin (Munich); 1991 Nov; 86(11):601-4. PubMed ID: 1685215
    [No Abstract]   [Full Text] [Related]  

  • 11. [The malignant neuroleptic syndrome].
    Pietzcker A
    Nervenarzt; 1988 Dec; 59(12):691-700. PubMed ID: 2905769
    [No Abstract]   [Full Text] [Related]  

  • 12. [Neuroleptic malignant syndrome and acute life-threatening catatonia--two contrasting disease entities?].
    Heils A; Lesch KP
    Fortschr Neurol Psychiatr; 1997 Jan; 65(1):8-15. PubMed ID: 9132369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical risk factors for neuroleptic malignant syndrome.
    Berardi D; Dell'Atti M; Amore M; De Ronchi D; Ferrari G
    Hum Psychopharmacol; 2002 Mar; 17(2):99-102. PubMed ID: 12404699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuroleptic malignant syndrome. Case reports].
    Berardi D; Troia M; Veronesi L; Ferrari G
    Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuroleptic malignant syndrome].
    Bryois C; Bondolfi G
    Rev Med Suisse Romande; 1996 Sep; 116(9):713-7. PubMed ID: 8966472
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravenous administration of lisuride in the treatment of neuroleptic malignant syndrome.
    de Mari M; Lamberti P; Simone F; Iliceto G; Federico F; Ferrari E
    Funct Neurol; 1991; 6(3):285-8. PubMed ID: 1683852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: a report of five cases.
    Nisijima K; Ishiguro T
    J ECT; 1999 Jun; 15(2):158-63. PubMed ID: 10378156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and presentation of neuroleptic malignant syndrome in a state psychiatric hospital.
    Keck PE; Sebastianelli J; Pope HG; McElroy SL
    J Clin Psychiatry; 1989 Sep; 50(9):352-5. PubMed ID: 2570064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case study: neuroleptic malignant syndrome without pyrexia.
    Hynes AF; Vickar EL
    J Am Acad Child Adolesc Psychiatry; 1996 Jul; 35(7):959-62. PubMed ID: 8768358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risperidone-induced neuroleptic malignant syndrome: a case report and review.
    Meterissian GB
    Can J Psychiatry; 1996 Feb; 41(1):52-4. PubMed ID: 8919425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.